GeneNews (GEN) News Today → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free GEN Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVertex, Crispr Get Second FDA Approval for Gene Therapymsn.com - January 18 at 4:04 PMGene-editing treatment from Vertex and CRISPR cleared for second rare blood disordermsn.com - January 17 at 5:58 PMFDA expands use of newly approved CRISPR therapymsn.com - January 17 at 5:58 PMOhio St hires Texas A&M athletic director Ross Bjork to replace the retiring Gene Smithwashingtonpost.com - January 16 at 8:53 PMMutated gene thought to exist in just 4% of people could ‘help tackle obesity’msn.com - November 27 at 4:35 PMSickle-Cell Treatment Created With Gene Editing Wins U.K. Approvalnytimes.com - November 18 at 7:54 AMUK authorizes gene therapy for blood disorders in world firstmsn.com - November 17 at 3:18 PMMac Jones Losing Support of Patriots Teammates After Being Benched for Third Time, Reportmsn.com - November 16 at 8:25 AMGene Frenette: Mac Jones' decline with Patriots also a product of Bill Belichick negligenceusatoday.com - November 16 at 8:25 AMSarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzledmsn.com - October 31 at 10:37 PMSarepta Therapeutics Stock Dives After New Gene Therapy Datawsj.com - October 31 at 10:37 PMFDA panel considers gene therapy as a potential cure for the sickest sickle cell patientsmsn.com - October 31 at 5:37 PMOncology Molecular Diagnostics Market by 2031marketwatch.com - March 27 at 8:00 AMGlobal Colorectal Cancer Diagnostic Market Industry Insights, Drivers, Top Trends, Global Analysis, Forecast and Opportunities to 2030 By VMReportsmarketwatch.com - March 19 at 1:04 PMBiotech Stock Mailbag: GenVecthestreet.com - January 5 at 12:09 PMStageZero Life Sciences Ltd (SZLS)investing.com - February 23 at 4:51 PM Get GeneNews News Delivered to You Automatically Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report (Ad)Eager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.) [Get Your Insights Now] GEN Media Mentions By Week GEN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GEN News Sentiment▼0.000.49▲Average Medical News Sentiment GEN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GEN Articles This Week▼01▲GEN Articles Average Week Get GeneNews News Delivered to You Automatically Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Akumin News CloudMD Software & Services News Aurora Spine News DIAGNOS News Nova Leap Health News Aptose Biosciences News Ceapro News Kane Biotech News Covalon Technologies News MediPharm Labs News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:GEN) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 MediaBiden’s $374B Giveaway Into This SectorDTITop 5 AI Stocks to Buy for 2024Market Moving TrendsRevealed: The Unknown Biotech Powering AI in HealthcareBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneNews Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.